OpenAlex
PricingAboutJobs
Log inGet started
Work

A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)

HTML

Year: 1996
Type: article
Study design: Clinical Trial
Source: AIDS
DOI: 10.1097/00002030-199605000-00006
Authors: Daniel S. Stein, Douglas G. Fish, John A. Bilello, Sandra L. Preston, Gisele L. Martineau, George L. Drusano
Institution: Albany Medical College
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: indinavir, HIV protease inhibitors, HIV infection, pharmacokinetics, drug safety, CD4 count, viral load, soluble TNF receptor 2, antiretroviral therapy, mathematical modeling, two-compartment model, sigmoid Emax model, oral bioavailability, drug-drug interactions, adverse events, treatment-naive patients, treatment-experienced patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2078326422
FWCI: 17.92
Cites:
Cited by: 178
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms